Expands high-precision surgical consumables business
Healthium Medtech, a global medtech company, has agreed to acquire a controlling stake in Paramount Surgimed, manufacturer and exporters of surgical blades, scalpels and dermal biopsy products. The non-surgical business of Paramount, including its lifestyle and hygiene business will be carved out prior to the transaction and retained with the Grover family.
With this move, Healthium will expand its specialised presence in the surgical consumables segment, where Paramount’s blades and dermal biopsy categories represent a logical extension of its existing business line. This alignment creates a two-way synergy, allowing Healthium to broaden the range of solutions it offers while enabling both organisations to serve their respective customer bases with a more comprehensive product line.
Anish Bafna, CEO and MD, Healthium Medtech, emphasised that the acquisition enhances Healthium’s global surgical consumables business and complements its strategy of delivering high-precision technology to healthcare professionals worldwide. “Paramount has earned the trust of clinicians across markets through consistent performance, rigorous execution and strong manufacturing excellence. As Paramount joins the Healthium family, our focus will be on ensuring a smooth integration that preserves what customers value, while also boosting service and supply reliability. We see this as an opportunity to align our collective strengths toward a more competitive global position in surgical consumables,” he said.
Shaily Grover, Managing Director of Paramount Surgimed, expressed confidence in the partnership and its future trajectory. “We are delighted to partner with Healthium, a leading player in the medtech space, for our surgical disposables business. Their operational expertise and established global reach makes them an ideal partner for our next phase of growth. Paramount has always stood for precision, quality and trust and we are confident the brand will grow significantly with Healthium. As we join forces, we will use the broader resources of a larger platform and an expanded portfolio to improve reliability and expand access across the markets we serve,” he said.
Daksh Grover, Director, Paramount Surgimed, envisions this partnership to be highly synergistic. As the company enters this new partnership, he remains committed to leading Paramount and delivering sustained high growth, ensuring continuity for customers while unlocking new opportunities across global markets. “This partnership paves the way for an unprecedented scale of impact. With our combined product portfolio and global capabilities, we believe we are well positioned to redefine the global surgical consumables landscape and move with a speed and scale never seen before,” he said.
